Big Biopharma in the red in early trade

|By:, SA News Editor

The big players in biopharma are faring a bit better than generic players in early trading. Investors appear to be lumping most drug makers together as they head for the exits after the NYT article.

Selected tickers: (JNJ)(ABBV -0.4%)(AGN +0.1%)(AZN -0.1%)(BMY -0.3%)(LLY -0.9%)(GSK -0.1%)(MRK -1.3%)(PFE -0.8%)(NVS -0.5%)(OTCQX:RHHBY +0.3%)(NVO -0.3%)(VRX -3.6%)

Previously: Hospital groups planning to enter generic drugs business (Jan. 18)

Subscribe for full text news in your inbox